X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-03-10 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $3.37 | +10,000 | 6,021,873 | 0% | +$33,700 | ||||||
2023-02-27 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $3.98 | +20,000 | 6,011,873 | 0% | +$79,600 | ||||||
2023-02-15 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $3.86 | +20,000 | 5,991,873 | 0% | +$77,200 | ||||||
2023-01-31 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $4.05 | +20,000 | 5,471,873 | 0% | +$81,000 | ||||||
2023-01-24 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $4.19 | +20,000 | 5,451,873 | 0% | +$83,800 | ||||||
M | 2022-11-22 | CMPX | Bisker-Leib Vered | COO | S - Sale | $4.23 | -24,500 | 1,060,414 | -2% | -$103,708 | |||||
M | 2022-11-18 | CMPX | Bisker-Leib Vered | COO | S - Sale | $4.36 | -22,261 | 1,084,914 | -2% | -$96,986 | |||||
2022-11-08 | CMPX | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $3.21 | +402,000 | 18,791,422 | +2% | +$1,290,420 | ||||||
2022-11-08 | CMPX | Gordon Carl L | Dir, 10% | P - Purchase | $3.21 | +402,000 | 18,791,422 | +2% | +$1,290,420 | ||||||
2022-09-28 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $2.32 | +10,000 | 5,431,873 | 0% | +$23,200 | ||||||
2022-09-26 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $2.27 | +15,000 | 5,421,873 | 0% | +$34,050 | ||||||
2022-09-07 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $3.03 | +15,000 | 5,406,873 | 0% | +$45,450 | ||||||
2022-09-01 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $2.83 | +15,000 | 5,391,873 | 0% | +$42,450 | ||||||
2022-08-17 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $3.05 | +15,000 | 5,376,873 | 0% | +$45,750 | ||||||
2022-08-10 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $2.64 | +15,000 | 5,361,873 | 0% | +$39,600 | ||||||
2022-08-01 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $2.58 | +15,000 | 5,346,873 | 0% | +$38,700 | ||||||
2022-06-21 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $2.80 | +20,000 | 5,331,873 | 0% | +$56,000 | ||||||
2022-06-16 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $2.34 | +20,000 | 5,311,873 | 0% | +$46,800 | ||||||
2022-06-13 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $2.29 | +30,000 | 5,291,873 | +1% | +$68,700 | ||||||
2022-06-06 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $2.83 | +30,000 | 5,261,873 | +1% | +$84,900 | ||||||
2022-06-01 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $3.03 | +20,000 | 5,231,873 | 0% | +$60,600 | ||||||
2022-05-26 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $3.04 | +20,000 | 5,211,873 | 0% | +$60,800 | ||||||
2022-05-23 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $2.72 | +18,355 | 5,191,873 | 0% | +$49,926 | ||||||
2022-05-17 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $2.47 | +20,215 | 5,173,518 | 0% | +$49,931 | ||||||
M | 2022-05-11 | CMPX | Gordon Carl L | Dir, 10% | P - Purchase | $2.18 | +192,516 | 18,389,422 | +1% | +$420,482 | |||||
M | 2022-05-11 | CMPX | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $2.18 | +192,516 | 18,389,422 | +1% | +$420,482 | |||||
M | 2022-05-06 | CMPX | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $1.57 | +125,359 | 18,196,906 | +1% | +$197,252 | |||||
M | 2022-05-06 | CMPX | Gordon Carl L | Dir, 10% | P - Purchase | $1.57 | +125,359 | 18,196,906 | +1% | +$197,252 | |||||
2022-05-10 | CMPX | Schuetz Thomas J. | CEO | P - Purchase | $1.80 | +27,836 | 5,153,303 | +1% | +$50,105 | ||||||
2021-11-04 | CMPX | Gordon Carl L | Dir, 10% | P - Purchase | $3.50 | +5,357,143 | 3,571,428 | -300% | +$18,750,001 | ||||||
2021-11-04 | CMPX | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $3.50 | +5,357,143 | 3,571,428 | -300% | +$18,750,001 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |